Authored by: Matt Wadyka, President, US Medical Affairs, Inizio Medical
Oncology is evolving: Beyond survival to quality of life
Oncology is changing, fast. With new therapies and personalized treatments helping patients live longer, the definition of success in cancer care is evolving. But longevity alone isn’t the goal – quality of life, lived experience, and long-term well-being must also take center stage.
The expanding role of Medical Affairs in oncology
That’s where Medical Affairs can play a vital role: as a bridge between science and the human stories behind the data.
Traditionally focused on communicating scientific evidence and supporting regulatory or commercial needs, Medical Affairs is now expanding its remit. It’s no longer enough to simply deliver the data – teams must also elevate the patient voice.
Why patient-centricity matters in cancer care
This means shaping strategy around what truly matters to those living with cancer, both during and after treatment.
Chronic side effects, cognitive decline, fertility concerns, and emotional stress can affect survivors for years. Addressing these realities calls for earlier and deeper patient engagement, well beyond end-of-trial questionnaires.
From passive participants to strategic partners
From co-designing trials to contributing on advisory boards, patients are increasingly seen as strategic partners, not passive participants.
Yet this shift comes with a caution: avoiding tokenism. Truly patient-first approaches must reflect a diversity of experiences and ensure insights are meaningfully embedded into decision-making processes – not just captured and shelved.
How Medical Affairs can champion patient-first oncology
Medical Affairs is uniquely positioned to lead this change, connecting clinical insight with empathy and aligning research with real-world needs.
To explore how Medical Affairs can champion patient-first oncology, read the full article now live on PMLive.
